Nortriptyline
TCA • Last reviewed 2025-09-27
Brands: Pamelor
Sources updated 2025 • 1 references
General Information
Indicated for: Depression (particularly endogenous); consider cardiac precautions. TCA
Dosage & Administration
Typical dose range: 50–150 mg/day (divided or once nightly)
Therapeutic level: Target 50–150 ng/mL (therapeutic drug monitoring).
Indications (label)
Depression (particularly endogenous); consider cardiac precautions.
View labelExact
Mechanism (brief)
Tricyclic antidepressant; primarily norepinephrine reuptake inhibition with anticholinergic properties.
Metabolism & Half‑life
- Metabolism: CYP2D6 to 10-hydroxynortriptyline; genotype affects clearance.
- Half‑life: ~18–90 h.
Therapeutic Drug Monitoring (TDM)
Recommended: No
References
- Nortriptyline labelExact (2025)